Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>Kanglaite (KLT) is an active extract of the Coix lacryma-jobi seed, which can benefit Qi and nourish Yin, and disperse the accumulation of evils. It is used as a biphasic broad-spectrum anti-cancer drug, and shows synergistic effects with radiotherapy and chemotherapy. However, the mechanism of KLT combined with cisplatin (CDDP) against hepatocellular carcinoma (HCC) has not been elucidated.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim of the study</h3><p>The aim of present study was to investigate the potential synergistic effects of KLT and CDDP on HepG2 cells, discussing the possible mechanisms from the perspective of CKLF1 and NF-κB mediated inflammatory response and chemoresistance, and the involvement of drug efflux transporters.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>CDDP injured HepG2 cells were used to investigate the effects of KLT on chemotherapeutics treated HCC. Effects of KLT pretreatment on CDDP injured HepG2 cells were determined by MTT, wound healing assay, and transwell assay. Expression of chemokine-like factor 1 (CKLF1) and activation of nuclear factor κB (NF-κB) were examined by qPCR, western blot, and immunofluorescence staining. Furthermore, to study the role of CKLF1 in KLT mediated effects on this CDDP injured HCC cell model, HepG2 cells overexpressed with CKLF1 gene were used. Cell viability and NF-κB activation were investigated. Moreover, TNF-α and IL-1β levels were measured by Elisa analysis and western blot to evaluate the inflammatory response. Additionally, ATP-binding cassette (ABC) drug efflux transporters, MDR1, MRP2, and BCRP were also determined in present study.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>KLT pretreatment followed by CDDP treatment was found to show synergistic effects, which showed by decreased cell viability, migration and invasion ability of HepG2 cells. Expression of CKLF1 enhanced significantly in CDDP treated HepG2 cells, and KLT decreased this elevation obviously. Furthermore, CDDP activated NF-κΒ and promoted translocation of NF-κB toward the nucleus. KLT inhibited the activation of NF-κΒ, which sensitized cancer cells. Overexpression of CKLF1 reversed the effects of KLT on CDDP injured HepG2 cells, which exhibited by increased cell viability and enhanced activation of NF-κΒ. CDDP induced NF-κΒ activation could also lead to excessive inflammatory response, and KLT can suppress the aggravating inflammation which may be beneficial for tumor progression. Furthermore, we found that ABC drug efflux transporters MDR1, MRP2, and BCRP in CDDP treated HepG2 cells were decreased when pretreated with KLT.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>KLT pretreatment may increase the effects of CDDP on HepG2 cells, by exhibiting cooperative effects on suppression of HepG2 cells. The mechanisms may partly by inhibiting CKLF1 mediated NF-κB pathway, which may contribute to inflammation of tumor microenvironment and chemoresistance of CDDP. Inhibition of transporter-mediated drug efflux is also involved in KLT mediated sensitization effects of CDDP.</p>

Mechanism and Anti-liver Tumor Metastasis Activity of the Kang Lai Te Injection

A Research on the KangLaiTe Lnjection in Treating the Liver Metastasis

The effect of the transfer of lak cells, combined with alloimmunization, on the pulmonary metastases of rat mammary carcinoma

Effect of Kanglaite Injection on Plasma Osteopontin of Human Colon Carcinoma Liver Metastasis Model in Nude Mice

Antitumor Effects Of Interleukin-18 Gene-Modified Hepatocyte Cell Line On Implanted Liver Carcinoma

Study on the Apoptosis of Renal Cancer Cells and the Expression of FAS/APO-1 and BCL-2 Genes Induced by Kanglaite Injection

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

Intervention of Spleen-Nourishing and Qi-Enriching Herbs on Liver Metastasis of B16 Melanoma Grafted in Mice

Influence of Kanglaite injection on expression of proliferating cell nuclear antigen in Lewis lung cancer mice

The intervention effect of Aitongxiao prescription on primary liver cancer rats was evaluated based on high-throughput miRNA sequencing and bioinformatics analysis

Clinical Observation in Kanglaite Injection on Serum Alpha-Fetoprotein and Physical Conditions of Advanced Hepatocellular Carcinoma Patients

The Influence of the KLT Injection on the VEGF-C Proteinum Expression of Lewis Lung Cancer Mice

Transient Increased Expression of Vegf and Mmp-1 in A Rat Liver Tumor Model after Hepatic Arterial Occlusion

Mechanism of Interferon Alpha on Inhibition of Metastasis and Angiogenesis of Hepatocellular Carcinoma after Curative Resection in Nude Mice

Experimental animal models of pancreatic carcinogenesis and liver metastasis and me-tastasis-related molecules

The Relationship Between Lymphangiogenesis and Lymphatic Metastasis in Murine Hepatic Carcinoma of High and Low Metastatic Potentialities

Percutaneous local injection with sodium morrhuate for human liver cancer xenograft in nude mice

The Role and Mechanism of Low-Dose Aspirin with IFN-α in Inhibiting Growth and Metastasis of Hepatocellular Carcinoma

Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux

Analysis of the absorbed constituents and mechanism of liquidambaris fructus extract on hepatocellular carcinoma

Herbal Compound "songyou Yin" Reinforced the Ability of Interferon-Alfa to Inhibit the Enhanced Metastatic Potential Induced by Palliative Resection of Hepatocellular Carcinoma in Nude Mice.